Bristol-Myers Squibb
Bristol-Myers Squibb, one of the world’s largest pharmaceutical companies, arose out of a 1989 merger and today focuses on the manufacture of prescription medicines for the treatment of cancer, diabetes, cardiovascular disease, and psychiatric disorders. In 2021, the company took part in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, a collaboration with the National Institutes of Health, whose goal was to develop a national strategy for a coordinated COVID-19 research response. As part of the initiative, Bristol-Myers Squibb donated several of its products to trials aimed at assessing potential treatments for patients with COVID-19.
Regis Duvignau—Reuters
Company Information
As of 6/5/23
Country
U.S.
Headquarters
New York City
Industry
Pharmaceuticals
CEO
Giovanni Caforio
Website
Company Type
Public
Ticker
BMY
Revenues ($M)
$46,159
Profits ($M)
$6,327
Market Value ($M)
$145,780
Employees
34,300
Market value as of March 31, 2023.
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
2.95
EPS % Change (from 2021)
-5.4%
EPS % Change (5 year annual rate)
37.1%
EPS % Change (10 year annual rate)
9.8%
Total Return
Total Return to Investors (2022)
18.9%
Total Return to Investors (5 year, annualized)
6.4%
Total Return to Investors (10 year, annualized)
11.4%
World's Most Admired Companies
Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
-
Previous All-Star Rank
-
Industry Rank
7
Previous Industry Rank
6
Overall Score
6.9
Innovation
9
People Management
8
Use of Corporate Assets
12
Social Responsibility
7
Quality of Management
6
Financial Soundness
9
Long-Term Investment Value
7
Quality of Products/Services
10
Global Competitiveness
10
Key Financials (Last Fiscal Year)
($ Millions)
% change
Revenues ($M)
$46,385
9.1%
Profits ($M)
$6,994
-
Assets ($M)
$109,314
-
Total Stockholder Equity ($M)
$35,946
-
Profit Ratios
Profit as % of Revenues
15.1%
Profits as % of Assets
6.4%
Profits as % of Stockholder Equity
19.5%
Lists ranking Bristol-Myers Squibb
Latest news for Bristol-Myers Squibb
- Most Powerful Women 2021 - Building Brands With Purpose;49:13Conferences, MPW Summit;
- Brainstorm Health 2022 - Leveling The Playing Field: Transforming Patient Equity And Access;58:07Conferences, Brainstorm Health;
- Brainstorm Health 2022 - Accelerating Scientific Breakthroughs - The Power of Next Gen Therapies;46:16Conferences, Brainstorm Health;
- Bristol Myers Squibb CEO details promising acquisitions, healthcare message to Biden administration;7:58Series, On Leading;
